Biotech

All Articles

James Wilson leaving Penn to introduce two brand new biotechs

.After more than thirty years, gene therapy innovator James Wilson M.D., Ph.D., is actually leaving ...

3 biotechs try to trump the summertime heat through losing personnel

.As biotechs try to transform a new page in August, at least three providers have actually shed work...

venBio elevates $528M for fifth life scientific researches VC fund

.Pro venture capital organization venBio has actually lifted yet another half a billion dollars to i...

Otsuka pays out $800M for Jnana and also its own clinical-stage PKU drug

.Otsuka Drug has actually grabbed Boston-based Jnana Rehabs for $800 thousand so the Oriental biotec...

FibroGen gives up 75% people staff as possession fails 2 more trials

.FibroGen is actually substantially restructuring its service, laying off 75% of its own U.S. team a...

Tracon winds down weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has actually chosen to relax functions full weeks after an injectable immune...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M loss on failed epilepsy medicine, promotes FDA operate

.Our experts currently know that Takeda is hoping to find a road to the FDA for epilepsy medication ...

VBI Vaccines declare personal bankruptcy, seeks asset sale

.Immunology biotech VBI Vaccines is actually drifting precariously close to the moment of truth, alo...

Celldex anti-cKIT antitoxin lessen hives in an additional phase 2 study

.It's not easy to muscle in on a space as competitive as immunology, yet Celldex Therapies thinks th...